Genetic mechanisms underlying Duchenne muscular dystrophy point to potential treatments
Duchenne muscular dystrophy (DMD) is a rare hereditary disease that is associated with progressive muscle wasting. The ...
FiercePharma4h
Astellas shifts investment focus to later-stage opportunities amid reprioritization
Astellas has invested heavily in novel technologies that are not necessarily the most successful or popular in the industry.
Monthly Prescribing Reference5h
Troculeucel Gets Fast Track Status for Moderate Alzheimer Disease
The Fast Track designation is supported by data from the open-label phase 1 SNK01-MX04 trial, as well as preliminary data from the phase 1 cohort from the phase 1/2a SNK01-AD01 trial.
Biotech Alert: Searches spiking for these stocks today
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...